InvestorsHub Logo
Followers 1
Posts 211
Boards Moderated 0
Alias Born 07/16/2016

Re: hovacre post# 20394

Wednesday, 05/17/2017 7:52:14 PM

Wednesday, May 17, 2017 7:52:14 PM

Post# of 108192
One of the strenghts of this platform is the lack of strong secondary effects to patients ... with similar or better results than standard treatment (also it is cheaper as Price level and it needs a cheaper supply chain to administer than other solutions)

The market likes big flashy news, ADXS is a work horse, not a slick race one. Eventually the gold old boy will finish working the field and we should be able to reap the rewards.

The only thing that makes me nervous is the prostate trial .. this is the first trial in humans outside of the HPV área of influence.

Go Zen
Cheers

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News